Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 7.75
-0.75 (-8.82%)
Aug 7, 2026, 2:32 PM EST
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 21.55 million as of August 10, 2026. Its market cap has decreased by -3.07% in one year.
Market Cap
21.55M
Enterprise Value
20.97M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.75
ChartMarket Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 21.55M, a decrease of -98.50%. That is a compound annual growth rate of -36.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 21.55M | -31.65% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 36.00M |
| Telescope Innovations | 34.76M |
| Resverlogix | 32.66M |
| Sona Nanotech | 32.03M |
| Defence Therapeutics | 31.07M |
| Thiogenesis Therapeutics | 28.51M |
| Quantum BioPharma | 28.15M |
| Sharp Therapeutics | 27.37M |